NON-ALCOHOLIC FATTY LIVER DISEASE OUTCOMES FUNNEL
Introduction. Non-alcoholic fatty liver disease (NAFLD) is increasingly recognized as an important and common public health problem that can lead to cirrhosis and hepatic failure (hepatocellular carcinoma – HCC). It may be the most prevalent liver disease. However knowledge of the epidemiology is li...
Main Author: | |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IRBIS LLC
2015-12-01
|
Series: | Фармакоэкономика |
Subjects: | |
Online Access: | https://www.pharmacoeconomics.ru/jour/article/view/110 |
_version_ | 1826567968542162944 |
---|---|
author | D. V. Blinov |
author_facet | D. V. Blinov |
author_sort | D. V. Blinov |
collection | DOAJ |
description | Introduction. Non-alcoholic fatty liver disease (NAFLD) is increasingly recognized as an important and common public health problem that can lead to cirrhosis and hepatic failure (hepatocellular carcinoma – HCC). It may be the most prevalent liver disease. However knowledge of the epidemiology is limited. Most data came from studies conducted in Northern America, Western Europe, Japan and China. A first disease registry in NAFLD (DIREG_L_01903) was performed in 2007 in Russia. This study showed high prevalence of NAFLD within the GP-s patient flow (27%). These findings encourage to conduct a larger sample size study to evaluate the real prevalence of NAFLD in the Russian population and if this prevalence of NAFLD patients has changed in the last 7 years. |
first_indexed | 2024-04-10T02:40:04Z |
format | Article |
id | doaj.art-72ed69326c6a4680a3bbe4a073665eae |
institution | Directory Open Access Journal |
issn | 2070-4909 2070-4933 |
language | Russian |
last_indexed | 2025-03-14T11:15:58Z |
publishDate | 2015-12-01 |
publisher | IRBIS LLC |
record_format | Article |
series | Фармакоэкономика |
spelling | doaj.art-72ed69326c6a4680a3bbe4a073665eae2025-03-02T10:15:50ZrusIRBIS LLCФармакоэкономика2070-49092070-49332015-12-0183141910.17749/2070-4909.2015.8.3.014-01998NON-ALCOHOLIC FATTY LIVER DISEASE OUTCOMES FUNNELD. V. Blinov0The Russian National Research Medical University named after N.I. Pirogov of the Ministry of Health of the Russian Federation, MoscowIntroduction. Non-alcoholic fatty liver disease (NAFLD) is increasingly recognized as an important and common public health problem that can lead to cirrhosis and hepatic failure (hepatocellular carcinoma – HCC). It may be the most prevalent liver disease. However knowledge of the epidemiology is limited. Most data came from studies conducted in Northern America, Western Europe, Japan and China. A first disease registry in NAFLD (DIREG_L_01903) was performed in 2007 in Russia. This study showed high prevalence of NAFLD within the GP-s patient flow (27%). These findings encourage to conduct a larger sample size study to evaluate the real prevalence of NAFLD in the Russian population and if this prevalence of NAFLD patients has changed in the last 7 years.https://www.pharmacoeconomics.ru/jour/article/view/110epidemiologynafldnon-alcoholic fatty liver diseasenashnon-alcoholic steatohepatitishepatocellular carcinomahccprevalence |
spellingShingle | D. V. Blinov NON-ALCOHOLIC FATTY LIVER DISEASE OUTCOMES FUNNEL Фармакоэкономика epidemiology nafld non-alcoholic fatty liver disease nash non-alcoholic steatohepatitis hepatocellular carcinoma hcc prevalence |
title | NON-ALCOHOLIC FATTY LIVER DISEASE OUTCOMES FUNNEL |
title_full | NON-ALCOHOLIC FATTY LIVER DISEASE OUTCOMES FUNNEL |
title_fullStr | NON-ALCOHOLIC FATTY LIVER DISEASE OUTCOMES FUNNEL |
title_full_unstemmed | NON-ALCOHOLIC FATTY LIVER DISEASE OUTCOMES FUNNEL |
title_short | NON-ALCOHOLIC FATTY LIVER DISEASE OUTCOMES FUNNEL |
title_sort | non alcoholic fatty liver disease outcomes funnel |
topic | epidemiology nafld non-alcoholic fatty liver disease nash non-alcoholic steatohepatitis hepatocellular carcinoma hcc prevalence |
url | https://www.pharmacoeconomics.ru/jour/article/view/110 |
work_keys_str_mv | AT dvblinov nonalcoholicfattyliverdiseaseoutcomesfunnel |